Unión Europea -
islandés -
EMA (European Medicines Agency)
quviviq
idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - svefntruflun og viðhald - psycholeptics - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
valsartan krka filmuhúðuð tafla 160 mg
krka sverige ab - valsartanum inn - filmuhúðuð tafla - 160 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
stesolid tafla 5 mg
actavis group ptc ehf. - diazepamum inn - tafla - 5 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
stesolid tafla 2 mg
actavis group ptc ehf. - diazepamum inn - tafla - 2 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
stesolid endaþarmslausn 5 mg/2,5 ml
actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 5 mg/2,5 ml
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
stesolid endaþarmslausn 10 mg/2,5 ml
actavis group ptc ehf. - diazepamum inn - endaþarmslausn - 10 mg/2,5 ml
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
valsartan jubilant filmuhúðuð tafla 80 mg
jubilant pharmaceuticals nv - valsartanum inn - filmuhúðuð tafla - 80 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol mixtúra, dreifa 20 mg/ml
novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol tafla 200 mg
novartis healthcare a/s - carbamazepinum inn - tafla - 200 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol retard forðatafla 200 mg
novartis healthcare a/s - carbamazepinum inn - forðatafla - 200 mg